News
corneal injury
Corneal wounds are healed with a single drop from Living Eye Drops
This revolutionary new eye drop genetically modifies eye microbes to promote corneal wound treatment with just one drop.
age-related macular degeneration
Dry AMD patients may benefit from light therary
The double-masked, prospective randomized trial included 100 adults with dry AMD and evaluated whether a targeted light therapy could improve the vision in the participants.
cataract
Ocular inflammation drug to head to phase 3 clinical trial
Harrow, the manufacturer of TRIESENCE, hopes to expand the on-label usage of TRIESENCE for all cataract surgery patients.
geographic atrophy
Positive clinical trial results of wireless retinal implant
Results of a clinical trial testing a new wireless retinal implant were recently published in the New England Journal of Medicine.
Alzheimer's
Alzheimer's risk associate with common bacteria
A common bacteria that causes sinus infections and pneumonia may increase the risk of Alzheimer's.
Axpaxli
Successful Phase 3 study results for Ocular's Axpaxli wet AMD drug
Ocular Therpeutix announced successful results of their experimental drug Axpaxli in treating wet age-related macular degeneration.
diabetic retinopathy
The gut connection to diabetic retinopathy
Study results recently published in Gut, highlight the role that gut microbiome plays in diabetic retinopathy.
age-related macular degeneration
Diabetic drug associated with lower risk of progression of age-related macular degeneration
Drug commonly used to treat diabetes may lower risk of progression of age-related macular degeneration.
age related macular degeneration
Parkinson's medication may help lower risk progression of age-related macular degeneration
Levodopa is commonly prescribed to treat Parkinson's disease and a recent study found that it could possibly reduce the risk of progression from dry age-related macular degeneration (AMD) to the we...